Conventional fluoroscopy guides many radiology, cardiology, and vascular surgery procedures. While the use of fluoroscopy continues to grow, the current practice fails to take advantage of much richer and useful information present in preexisting CT and MR data that often dictate the need for such procedures. ACREW Imaging, a young, fast-growing startup led by domain and industry experts, is changing this practice. ACREW Imaging’s patent- and FDA clearance-pending advanced visualization technology, called F3, autonomously and accurately merges live fluoroscopic images with diagnostic CT/MR images in real time. F3 is increasing the precision and accuracy of the fluoroscopy-guided procedures. Other equally important benefits are decreased use of iodinated contrast, reduced radiation exposure to patients and staff, shorter procedure times, and efficient and expanded use of mobile and fixed fluoroscopy systems.
Company’s Keywords:
image fusion, image registration, cardiology, radiology, medical imaging, vascular surgery
<1
<
<2019
Your request has been submitted successfully.
Own or work here?